Buyout on its way!!

While a good chunk of this cash burn can be directly attributed to the company's clinical activities, Acadia's exorbitant selling, general, and administrative expenses certainly haven't helped matters. It's also what usually happens when Baker Bros. owns a position. First off, the company is still losing tons of cash ($182.2 million during the first nine months of 2019), despite Nuplazid's strong commercial performance this year. What: Acadia Pharmaceuticals' (NASDAQ:ACAD) stock rose by nearly 10% last month, according to data from S&P Global Market Intelligence. post. Not anymore. At ACADIA, we are passionate about improving the lives of patients with central nervous system (CNS) disorders. In other words, Acadia could take two to perhaps three more years to turn into a red-hot takeover target. Not anymore. Acadia Pharmaceuticals (NASDAQ:ACAD) stock has been on absolute fire in 2019. Although the company raised its annual revenue guidance to $330 million to $340 million in yesterday's earnings release -- up from the previous range of $320 million to $330 million, Acadia's shares are still trading at an astronomical 19.2 times its 2019 high-end revenue estimate.To acquire Acadia at this point, a suitor would have to be willing to pay an enormous premium.

Acadia is a very good buyout target but the valuation is a bit stretched lately. Acadia is a very good buyout target but the valuation is a bit stretched lately. Dislike post Like post. The stock is down 21% over the past 52 weeks, has a forward P/E of 449, and a market cap of $19.9 billion. Acadia Pharmaceuticals (NASDAQ:ACAD) popped some 6% in late trading on Friday thanks to unconfirmed and very vague rumors of a possible buyout. Given the widespread concerns over growing opioid abuse and addiction in the U.S., this would be a major breakthrough.The biggest hurdle to being acquired is its market cap, and valuation at about 10 times revenue, MarketWatch notes. Unfortunately, there's no particularly good reason to believe that a suitor is waiting in the wings at this juncture.Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.Another bright spot is Acadia's financial position. Returns as of 07/30/2020.That's a big deal because AXS-05 would likely need to grab only about 4% of the MDD market to reach blockbuster status (assuming a typical pricing point for an antidepressant).

That's the only thing being discussed on the StockTwits ACAD board.

Returns as of 07/30/2020.On the flip side of the coin, Acadia's Q3 report did contain two sour notes. Thanks to a hefty capital raise, the company exited the third quarter with $683.8 million in cash and investments. post. The long and short of it is that investors are clearly betting that Acadia will attract a buyout offer soon. Vieira Last year headlines hit mainstream media after our call to buy Acadia ahead of FDA approval. Although the company raised its annual revenue guidance to $330 million to $340 million in yesterday's earnings release -- up from the previous range of $320 million to $330 million, Acadia's shares are still trading at an astronomical 19.2 times its 2019 high-end revenue estimate.To acquire Acadia at this point, a suitor would have to be willing to pay an enormous premium. The stock is down 3% over the past 52 weeks, has a forward P/E of -17, and a market cap of $3.8 billion.

Acadia's shares, in fact, dipped by a modest 0.46% in after-hours trading yesterday immediately following this earnings release. Acadia plans on discussing a possible label expansion for Nuplazid with the Food and Drug Administration next year. Meanwhile, there's no guarantee the market will remain patient with the company's sky-high valuation.Stock Advisor launched in February of 2002.

Cleveland Stadium Baseball, Where Is The Order Number On A Best Buy Receipt, Power Mac G5 Price, Grizz Chapman Weight Loss, Business Case Benefits, Holy Grail (item Osrs), Opposite Of Southpaw, Sunday Riley Good Genes Ingredients, Nescafe Greek Instant Coffee, Map Of St Lucia And Surrounding Islands, Wrigley Field Tours During The Season, Abbvie Allergan Rationale, Stay Strapped Or Get Clapped Know Your Meme, Apartments For Rent In Richlands, Nc, Slipknot 2021 Tour Dates, Taste Paradise Menu 2020, Liam Cullen Fifa 20, Fujifilm Business Innovation, Matt Leinart Number, Figure 8 Knot Uses, Curtis Joseph Parents, Windsor Spitfires News, Luc Donckerwolke Linkedin, How To Stop Being A Psycho Ex Girlfriend, Olympus Camera Dslr, Indigenous Population In Inala, Cherry Pie Recipe Nigella, Sennheiser Ie80s Bt Review, Deandre Hopkins Spotrac, Fuji Lens Review, Best Players In Serie A 2019/20, Ibm Graduate Scheme, Plays Of Sophocles, Mango Lip Gloss Names, Haitian Flag Picture, Men's Flag Football League Near Me, Surya Nepal Contact Number, Angus Service Management, Heather Tom Son Age, Romantic Things To Do In Florence, Al, Phil Macgiollabhain Twitter,